Saturday, December 06, 2025 | 03:09 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Volumes jump at Florence Investech counter

Image

Capital Market

GlaxoSmithKline Pharmaceuticals, Natco Pharma, Onelife Capital Advisors and Aurobindo Pharma are among the other stocks to see a surge in volumes on BSE today, 16 December 2013.

Florence Investech clocked volume of 5.36 lakh shares by 14:02 IST on BSE, a 817.6-times surge over two-week average daily volume of 1,000 shares. The stock was locked at 10% upper circuit at Rs 163.80.

GlaxoSmithKline Pharmaceuticals notched up volume of 73,000 shares, a 11.91-fold surge over two-week average daily volume of 6,000 shares. The stock spurted 18.82% at Rs 2,933 after its overseas parent GlaxoSmithkline plc announced a voluntary open offer to acquire additional 2.06 crore equity shares of the company at Rs 3,100 per share.

 

GlaxoSmithKline Pte along with GlaxoSmithkline plc announced a voluntary open offer to the public shareholders of GlaxoSmithkline Pharmaceuticals to acquire 2.06 crore equity shares, representing 24.33% stake of the total voting share capital of the company, at Rs 3,100 per share.

GlaxoSmithkline plc currently holds 50.67% stake in GlaxoSmithkline Pharmaceuticals. Its stake will rise to 75% if it gets the entire 2.06 crore equity shares through the voluntary open offer. The hike in stake will cost the overseas parent about Rs 6389 crore.

Natco Pharma saw volume of 1.51 lakh shares, a 9.44-fold surge over two-week average daily volume of 16,000 shares. The stock lost 0.15% at Rs 753.30.

Onelife Capital Advisors clocked volume of 2.24 lakh shares, a 8.14-fold surge over two-week average daily volume of 28,000 shares. The stock surged 15.72% to Rs 302.20.

Aurobindo Pharma clocked volume of 10.21 lakh shares, a 4.66-fold surge over two-week average daily volume of 2.19 lakh shares. The stock surged 7.92% at Rs 334.40.

Powered by Capital Market - Live News

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 16 2013 | 1:58 PM IST

Explore News